STOCK TITAN

Nkarta to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nkarta (Nasdaq: NKTX), a biopharmaceutical company specializing in engineered natural killer (NK) cell therapies for cancer, has announced participation in three upcoming investor conferences. The Cowen IO Next Summit will take place on November 11, 2022, followed by the Stifel Healthcare Conference on November 15, 2022, and the Evercore ISI HealthCONx Conference on November 29, 2022. Each event will feature a fireside chat, and webcasts will be available on Nkarta's website, with replays accessible for 90 days.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at three upcoming investor conferences:

Cowen IO Next Summit
November 11, 2022
10:40 a.m. ET – fireside chat

Stifel Healthcare Conference
November 15, 2022
8:35 a.m. ET – fireside chat

Evercore ISI HealthCONx Conference
November 29, 2022
11:20 a.m. ET – fireside chat

A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com


FAQ

What conferences is Nkarta participating in November 2022?

Nkarta is participating in the Cowen IO Next Summit on November 11, Stifel Healthcare Conference on November 15, and Evercore ISI HealthCONx Conference on November 29, 2022.

What is the stock symbol for Nkarta?

The stock symbol for Nkarta is NKTX.

Where can I watch Nkarta's investor conference presentations?

Nkarta's investor conference presentations will be streamed live on their website, and replays will be available for about 90 days.

What type of therapies does Nkarta develop?

Nkarta develops engineered natural killer (NK) cell therapies aimed at treating cancer.

When will Nkarta's fireside chat at the Cowen IO Next Summit take place?

Nkarta's fireside chat at the Cowen IO Next Summit is scheduled for November 11, 2022, at 10:40 a.m. ET.

How can I contact Nkarta for media inquiries?

For media inquiries, contact Greg Mann at Nkarta via email at gmann@nkartatx.com.

Nkarta, Inc.

NASDAQ:NKTX

NKTX Rankings

NKTX Latest News

NKTX Stock Data

171.13M
65.43M
4.87%
99.86%
12.11%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO